Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 19, 2020, titled "Zydus Cadila receives tentative approval from USFDA for Tofacitinib Extended-Release Tablets".
Press Release Oct 19 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Oct 17 2020
- Press Release Oct 16 2020
- Press Release Oct 08 2020
- Press Release Sep 25 2020
- Press Release Sep 24 2020
Later from Zydus Lifesciences
- Press Release Oct 20 2020
- Press Release Oct 23 2020
- Press Release Oct 29 2020
- Press Release Nov 02 2020
- Press Release Nov 03 2020
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences